Drug Trial Radar · NCT01178125
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
Last checked: Nov 19, 2026Latest source record: Nov 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,858
Actual
Start
Aug 2010
Primary completion
Jan 2013
Study completion Jan 2013
Sponsor
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.Teva (TEVA)
- Sponsor type
- Industry
- First posted
- Aug 9, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- Female only, from 18 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is an open-label, single treatment study. All subjects will receive 12 months of oral contraceptive therapy with DR-102. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a daily diary.
Conditions
- Contraception
- Female Contraception
Interventions
DR-102Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- All Users Pregnancy Rates Based on Pearl Index (PI) Analyses for 28-Day Cycles and Broken Out by Subpopulations Defined by Participant Weight, Using the 7-Day RuleTime frame: thirteen 28-day cycles
- Typical-Use Pregnancy Rates Based on Pearl Index (PI) Analyses for 28-Day Cycles and Broken Out by Subpopulations Defined by Participant Weight, Using the 7-Day RuleTime frame: thirteen 28-day cycles
- Compliant-Use Pregnancy Rates Based on Pearl Index (PI) Analyses for 28-Day Cycles and Broken Out by Subpopulations Defined by Participant Weight, Using the 7-Day RuleTime frame: thirteen 28-day cycles
Locations
62 sites in 2 countries. Site status is shown where the registry gives one.
Teva Investigational Site 10007
Montgomery, Alabama
Teva Investigational Site 10013
Phoenix, Arizona
Teva Investigational Site 10017
Phoenix, Arizona
Teva Investigational Site 10032
Little Rock, Arkansas
Teva Investigational Site 10026
San Diego, California
Teva Investigational Site 10056
San Diego, California
Teva Investigational Site 10002
Colorado Springs, Colorado
Teva Investigational Site 10033
Colorado Springs, Colorado
Teva Investigational Site 10057
Washington D.C., District of Columbia
Teva Investigational Site 10052
Clearwater, Florida
Teva Investigational Site 10021
Jacksonville, Florida
Teva Investigational Site 10036
Leesburg, Florida
Teva Investigational Site 10012
Miami, Florida
Teva Investigational Site 10015
Miami, Florida
Teva Investigational Site 10055
Palm Beach Gardens, Florida
Teva Investigational Site 10001
West Palm Beach, Florida
Teva Investigational Site 10031
Decatur, Georgia
Teva Investigational Site 10041
Roswell, Georgia
Teva Investigational Site 10050
Savannah, Georgia
Teva Investigational Site 10008
Louisville, Kentucky
Teva Investigational Site 10023
Mount Sterling, Kentucky
Teva Investigational Site 10048
Lawrenceville, New Jersey
Teva Investigational Site 10030
Moorestown, New Jersey
Teva Investigational Site 10014
Albuquerque, New Mexico
Teva Investigational Site 10006
Rochester, New York
Teva Investigational Site 10044
Cary, North Carolina
Teva Investigational Site 10040
Charlotte, North Carolina
Teva Investigational Site 10034
New Bern, North Carolina
Teva Investigational Site 10018
Winston-Salem, North Carolina
Teva Investigational Site 10046
Winston-Salem, North Carolina
Teva Investigational Site 10022
Columbus, Ohio
Teva Investigational Site 10039
Columbus, Ohio
Teva Investigational Site 10028
Oklahoma City, Oklahoma
Teva Investigational Site 10043
Philadelphia, Pennsylvania
Teva Investigational Site 10003
Pittsburgh, Pennsylvania
Teva Investigational Site 10049
Bluffton, South Carolina
Teva Investigational Site 10037
Columbia, South Carolina
Teva Investigational Site 10035
Greenville, South Carolina
Teva Investigational Site 10047
Mt. Pleasant, South Carolina
Teva Investigational Site 10016
Jackson, Tennessee
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.